Skip to main content

Carl Zeiss Meditec AG (CZMWF) Stock

Carl Zeiss Meditec AG Stock Details, Movements and Public Alerts

Stock Details

Carl Zeiss Meditec AG (CZMWF), a prominent company in the healthcare sector within the medical instruments & supplies industry, is based in Germany and primarily trades on the PNK.Currently, the stock is trading at $26.42. Over the past 52 weeks, it has ranged between $28.87 and $70.88. This places the current price at 37.3% of its 52-week high and -8.5% above its 52-week low. Recent trading volume was recorded at 100. The 14-day Relative Strength Index (RSI) stands at 26.05, suggesting oversold conditions. The stock is currently trading below its 50-day moving average of $36.02 by 26.65%. Similarly, it is below its 200-day moving average of $50.18 by 47.35%. The MACD histogram is 0.04, indicating bullish momentum (MACD Line: -1.86, Signal Line: -1.90). There are currently 3 active alerts set for CZMWF by users.

52-Week Range

$70.88 - $28.87

-62.73% from high · +-8.49% from low

Avg Daily Volume

37

20-day average

100-day avg: 82

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

18.18

Near market average

Forward P/E

12.82

Earnings expected to grow

Price to Book

1.21

EV/EBITDA

10.77

EPS (TTM)

$1.84

Price to Sales

1.33

Beta

1.41

Similar volatility to market

Q:How is CZMWF valued relative to its earnings and growth?
Carl Zeiss Meditec AG trades at a P/E ratio of 18.18, which is near the market average of approximately 20, suggesting the market views it as fairly valued relative to its earnings. Looking ahead, the forward P/E of 12.82 is lower than the current P/E, indicating analysts expect earnings to grow over the next year.
Q:What is CZMWF's risk profile compared to the market?
With a beta of 1.41, Carl Zeiss Meditec AG is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 1.21 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

5.47%

Operating Margin

-0.06%

EBITDA

$248.64M

Return on Equity

5.82%

Revenue Growth (YoY)

-4.80%

Q:How profitable and efficient is CZMWF's business model?
Carl Zeiss Meditec AG achieves a profit margin of 5.47%, meaning it retains $5.47 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -0.06% reveals how efficiently the company runs its core business operations before interest and taxes.
Q:What are CZMWF's recent growth trends?
Carl Zeiss Meditec AG's revenue declined by 4.80% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. These growth metrics should be evaluated against Medical Instruments & Supplies industry averages for proper context.

Dividend Information

Dividend Per Share

$0.65

Dividend Yield

2.46%

Q:What dividend income can investors expect from CZMWF?
Carl Zeiss Meditec AG offers a dividend yield of 2.46%, paying $0.65 per share annually. This above-average yield of 2-4% provides meaningful income while still allowing the company to reinvest for growth. It compares favorably to the S&P 500 average and offers competitive returns versus bonds in the current rate environment.
Q:How reliable is CZMWF's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - Carl Zeiss Meditec AG pays $0.65 per share in dividends against earnings of $1.84 per share, resulting in a payout ratio of 35.33%. This balanced payout between 30-60% suggests a sustainable dividend policy that allows both shareholder returns and business reinvestment. The dividend appears well-covered by earnings.

Company Size & Market

Market Cap

$2.9B

Revenue (TTM)

$2.20B

Revenue/Share (TTM)

$25.59

Shares Outstanding

87.54M

Book Value/Share

$27.71

Asset Type

EQUITY

Q:What is CZMWF's market capitalization and position?
Carl Zeiss Meditec AG has a market capitalization of $2.9B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 87.54M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Medical Instruments & Supplies industry, it competes with other firms in this sector.
Q:How does CZMWF's price compare to its book value?
Carl Zeiss Meditec AG's book value per share is $27.71, while the current stock price is $26.42, resulting in a price-to-book (P/B) ratio of 0.95. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Mar 17, 2026, 02:03 AM

Technical Indicators

RSI (14-day)

26.05

Oversold

50-Day Moving Average

$36.02

-26.65% below MA-50

200-Day Moving Average

$50.18

-47.35% below MA-200

MACD Line

-1.86

MACD Signal

-1.90

MACD Histogram

0.04

Bullish

Q:What does CZMWF's RSI value tell investors?
The RSI (Relative Strength Index) for CZMWF is currently 26.05, indicating the stock is in oversold territory (below 30). This indicates heavy selling pressure that may have pushed the price too low too fast. Oversold readings can present buying opportunities, but stocks can remain oversold in strong downtrends. Look for RSI to rise above 30 as a potential recovery signal. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret CZMWF's MACD and moving average crossovers?
MACD analysis shows the MACD line at -1.86 above the signal line at -1.90, with histogram at 0.04. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($36.02) is below the 200-day MA ($50.18), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Mar 17, 2026, 12:59 AM

Active Alerts

Alert Condition
Forward P/E falls below
Threshold
9.8 x
Created
Mar 16, 2026, 04:34 PM
Alert Condition
RSI Threshold Cross
Threshold
30
Created
Mar 10, 2026, 03:52 PM
Alert Condition
Earnings Announcement
Threshold
3 days
Created
Jan 26, 2026, 05:13 PM

Stay Ahead of the Market with Carl Zeiss Meditec AG Alerts

Set up price alerts for Carl Zeiss Meditec AG and get notified instantly when the price hits your target. Never miss an important price movement again.